Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for February 23rd

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 23rd:

The Estée Lauder Companies Inc. (EL - Free Report) :This company that manufactures and markets skin care, makeup, fragrance, and hair care products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.

 

Estée Lauder’s shares gained 14.1% over the last one month compared to S&P 500’s rise of +1.6%. The company possesses a Momentum Score of B.

 

Ultra Clean Holdings, Inc. (UCTT - Free Report) :This company that designs, develops, prototypes, engineers, manufactures, and tests production tools, modules, and subsystems has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.1% over the last 60 days.

 

Ultra Clean Holdings’ shares gained 13.2% over the last one month. The company possesses a Momentum Score of A.

 

iRobot Corporation (IRBT - Free Report) : This company that designs, builds, and sells robots has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 37.1% over the last 60 days.

 

iRobot Corp.’s shares gained 4.9% over the last one month. The company possesses a Momentum Score of A.

 

Waterstone Financial, Inc. (WSBF - Free Report) :This company that operates as a bank holding company for WaterStone Bank SSB has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.9% over the last 60 days.

 

Waterstone Financials’ shares gained 3.1% over the last one month. The company possesses a Momentum Score of B.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in